5-Bromo-6-methyl-1H-benzo[d]imidazole

Catalog No. :
ACBVQL415
CAS No. :
116106-16-2
Molecular Formula :
C8H7BrN2
Molecular Weight :
211.06

IUPAC Name:5-bromo-6-methyl-1H-benzo[d]imidazole

5-Bromo-6-methyl-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$52.00Login to see priceIn stockIn stock
1g97%$125.00Login to see priceIn stockIn stock
5g97%$373.00Login to see priceIn stockInquiry
25g97%$1772.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-methyl-1H-benzo[d]imidazole
IUPAC Name5-bromo-6-methyl-1H-benzo[d]imidazole
MDL No.MFCD11846340
Molecular FormulaC8H7BrN2
Molecular Weight211.06
SMILESCC1=C(Br)C=C2C(NC=N2)=C1
InChI KeyZQHHVSZEBVWTRO-UHFFFAOYSA-N
Synonym5-BROMO-6-METHYL-1H-BENZIMIDAZOLE;5-broMo-6-Methyl-1H-benzo[d]iMidazole;1H-BenziMidazole, 6-broMo-5-Methyl-;100184;6-Bromo-5-methylbenzimidazole;6-bromo-5-methyl-1H-benzimidazole
CAS No.116106-16-2
PubChem CID20784900

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACBVQL415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCNR280 route compound structure diagram
    ACMCNR280102169-44-8 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACBVQL415 route product structure diagram
    ACBVQL415116106-16-2 In Stock
Inquiry

2. ACBVQL415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCNR280 route compound structure diagram
    ACMCNR280102169-44-8 In Stock
  2. Plus
  3. ACCNZH713 route compound structure diagram
    ACCNZH71384661-56-3 In Stock
  4. Then
  5. ACBVQL415 route product structure diagram
    ACBVQL415116106-16-2 In Stock
Inquiry

Comments (0)